Enterprise Financial Services Corp Insulet Corp Transaction History

Enterprise Financial Services Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $13,538 - $15,978	-52 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$225.52 - $304.06 $1,804 - $2,432	-8 Reduced 13.33%	52 $14,000
Q1 2021 May 13, 2021	BUY	$235.95 - $293.05 $2,595 - $3,223	11 Added 22.45%	60 $16,000
Q2 2020 Aug 04, 2020	BUY	$159.17 - $224.73 $2,865 - $4,045	18 Added 58.06%	49 $9,000
Q1 2020 May 15, 2020	BUY	$130.01 - $216.44 $4,030 - $6,709	31 New	31 $5,000
Q1 2019 Apr 26, 2019	SELL	$72.44 - $101.87 $1,593 - $2,241	-22 Closed	0 $0
Q4 2018 Jan 25, 2019	BUY	$73.27 - $105.19 $586 - $841	8 Added 57.14%	22 $2,000
Q3 2018 Oct 26, 2018	BUY	$81.43 - $108.13 $1,140 - $1,513	14 New	14 $1,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.